Taiwan Tech Arena (TTA) champions entrepreneurship and innovation, intending to build a vibrant international startup ecosystem in Taiwan. TTA envisions being the foundation of global tech ventures, the cultural fusing hub of startups, and the voice of Taiwan’s tech startups.
Taiwan Pavilion
Taiwan is located in the center of the Asia-Pacific region, with abundant medical resources, and diverse clusters of information and communication, semiconductor, and biomedical industries. It is suitable for the investment in development of precision health industries such as high-end medical materials, AI computing, and big data analysis. Taiwan medical device manufacturers have developed actively medical research and technology and we hope to cooperate with local industries, so it will be easier to enter the supply chain of major international brands. Metal Industries Research & Development Centre (MIRDC), a non-profit organization from Taiwan and assists Taiwan government to cultivate and reinforce the medical device industry in Taiwan. We also develop medical device products and technologies in industries including dental and orthopedic implants, devices, medical imaging, minimally invasive surgery instrument, and healthcare. | The biomedical industry is one of the six core strategic industries in Taiwan. It is an important power for Taiwan to play the leading role in global economy. With rich experiences of research, development and manufacturing, Taiwan excels in high-tech fields, clinical trials and biologics production. Continuing R&D support from government has created highly skilled workforce to innovate and advance the industry. Besides, Taiwan’s strategic location and grown-up supply chain make it an ideal partner for worldwide collaboration. There are more than 60 exhibitors and institutions in the Taiwan Pavilion this year, covering new drug development, CRO, CDMO, agriculture biotechnology, medical devices, precision medicine and smart health fields. Come and Join us to shape the future of precision health for all ages through collaboration and innovation with Taiwan’s thriving biomedical industry! | The biomedical industry is an important power for Taiwan to play the leading role in global economy. With rich experiences of research, development and manufacturing, Taiwan excels in high-tech fields, clinical trials and biologics production. Continuing R&D support from government has created highly skilled workforce to innovate and advance the industry. Besides, Taiwan’s strategic location and grown-up supply chain make it an ideal partner for worldwide collaboration. There are more than 60 exhibitors and institutions in the Taiwan Pavilion this year, covering new drug development, CRO, CDMO, agriculture biotechnology, medical devices, precision medicine and smart health fields. Come and Join us to shape the future of precision health for all ages through collaboration and innovation with Taiwan’s thriving biomedical industry! | BPIPO is honored to lead Taiwan’s delegation, featuring around 40 prominent companies and organizations specializing in new drug development, CDMO, regenerative medicine, agricultural biotechnology, precision medicine, and smart health. We warmly invite you to visit the Taiwan Pavilion and explore opportunities for collaboration. At our pavilion, you’ll discover not only innovative business partnerships but also insights into Taiwan’s supportive biomedical policies and unique research ecosystem. Taiwan has dedicated decades of effort to fostering a thriving biomedical industry, supported jointly by government initiatives and private sector innovation. This collaborative environment has successfully driven cross-domain growth and positioned Taiwan as a global biotechnology hub.
Taiwan Electrical and Electronic Manufacturers
Taiwan Electrical and Electronic Manufacturers’ Association (TEEMA), founded in 1948, is composed of over 3,000 member manufacturers engaged in the 16 major categories related to electrical and electronic industries, such like: ➢ Semiconductors, LCD Panels & related, Printed Circuit Boards, Electronic Components, ➢ Information Computing r
Taiwan Bio Industry Organization
About Association Since its founding in 1989, the Taiwan Bio Industry Organization (Taiwan BIO) has been promoting the interests of its members from industry, the government and academia as well as promoting the development of the biomedical industries and their contribution to Taiwan’s economy and people. The more than 100 organizations and 3,000 individuals that make up Taiwan BIO membership represent the entire life sciences industry spectrum, including from the biotechnology, pharmaceutical, diagnostics, medical devices and materials, agricultural biotechnology, and nutraceuticals sectors. | Since its founding in 1989, the Taiwan Bio Industry Organization (Taiwan BIO) has been promoting the interests of its members from industry, the government and academia as well as promoting the development of the biomedical industries and their contribution to Taiwan’s economy and people. The more than 100 organizations and 3,000 individuals that make up Taiwan BIO membership represent the entire life sciences industry spectrum, including from the biotechnology, pharmaceutical, diagnostics, medical devices and materials, agricultural biotechnology, and nutraceuticals sectors. Promoting the interests of our members Taiwan BIO works tirelessly for the interests of its members. With deep connections to government policy makers at all levels, Taiwan BIO advocates strongly for policies that will lead not only to the continued growth of the industry – both locally and internationally – but also to better opportunities for its members. Taiwan BIO pledges to represent equally all its members whether from Taiwan or abroad. Promoting international exchange and cooperation One of TBIO’s key responsibilities is organizing the annual BIO Asia–Taiwan international conference and exhibition, an annual week-long festival of biotech-themed events held in Taipei. Through this gathering, Taiwan BIO helps facilitate networking, licensing and cooperation opportunities between investors, researchers, biotech companies and other key stakeholders, with the event also playing an important role in improving Taiwan’s visibility within the global biotechnology community. Taiwan BIO also helps organize delegations to attend important overseas events, including a large combined industry-government delegation to the BIO International Convention held annually in North America. Promoting communication between government and industry In addition, Taiwan BIO organizes regular conferences, seminars and meetings inviting key industry leaders and government representatives to address members’ interests and concerns. In this way, Taiwan BIO acts as a bridge connecting the private sector, academia, government, and international interests. Cultivating biotechnology industry talent In 2015 Taiwan BIO helped establish the Bio Industry Academy (BIA), a training organization with a mission to better prepare local talent for employment in Taiwan’s growing biopharmaceutical sector, and to upgrade the industry as a whole. Training topics offered by BIA to date include new drug development, manufacturing processes, industry-related business, finance and management, among others. BIA is currently offering over 300 hours of courses each year and has so far helped prepare more than 200 specialists to high-level placement within this demanding industry. Encouraging outstanding performance and innovation Taiwan BIO organizes the annual Taiwan Bio-Industry Organization Awards, with the awards ceremony coinciding with BIO Asia–Taiwan. Winners are recognized in Outstanding Company of the Year, Emerging Company of the Year, and Innovation of the Year categories. In doing so, Taiwan BIO aims to recognize local achievements and encourage innovation within this important industry, helping facilitate its further growth and the development of the entire biotechnology ecosystem. | Since its founding in 1989, the Taiwan Bio Industry Organization (Taiwan BIO) has been promoting the interests of its members from industry, the government and academia as well as promoting the development of the biomedical industries and their contribution to Taiwan’s economy and people. The more than 100 organizations and 3,000 individuals that make up Taiwan BIO membership represent the entire life sciences industry spectrum, including from the biotechnology, pharmaceutical, diagnostics, medical devices and materials, agricultural biotechnology, and nutraceuticals sectors. Taiwan BIO works tirelessly for the interests of its members. With deep connections to government policy makers at all levels, Taiwan BIO advocates strongly for policies that will lead not only to the continued growth of the industry – both locally and internationally – but also to better opportunities for its members. Taiwan BIO pledges to represent equally all its members whether from Taiwan or abroad. One of TBIO’s key responsibilities is organizing the annual BIO Asia–Taiwan international conference and exhibition, an annual week-long festival of biotech-themed events held in Taipei. Through this gathering, Taiwan BIO helps facilitate networking, licensing and cooperation opportunities between investors, researchers, biotech companies and other key stakeholders, with the event also playing an important role in improving Taiwan’s visibility within the global biotechnology community. Taiwan BIO also helps organize delegations to attend important overseas events, including a large combined industry-government delegation to the BIO International Convention held annually in North America. In addition, Taiwan BIO organizes regular conferences, seminars and meetings inviting key industry leaders and government representatives to address members’ interests and concerns. In this way, Taiwan BIO acts as a bridge connecting the private sector, academia, government, and international interests. In 2015 Taiwan BIO helped establish the Bio Industry Academy (BIA), a training organization with a mission to better prepare local talent for employment in Taiwan’s growing biopharmaceutical sector, and to upgrade the industry as a whole. Training topics offered by BIA to date include new drug development, manufacturing processes, industry-related business, finance and management, among others. BIA is currently offering over 300 hours of courses each year and has so far helped prepare more than 200 specialists to high-level placement within this demanding industry. Taiwan BIO organizes the annual Taiwan Bio-Industry Organization Awards, with the awards ceremony coinciding with BIO Asia–Taiwan. Winners are recognized in Outstanding Company of the Year, Emerging Company of the Year, and Innovation of the Year categories. In doing so, Taiwan BIO aims to recognize local achievements and encourage innovation within this important industry, helping facilitate its further growth and the development of the entire biotechnology ecosystem.
Taipei International Bakery Show
The Taipei Bakery Association (TBA), originally established as a dessert association in 1946, has long served as a cornerstone of Taiwan’s baking industry. It has played a pivotal role in promoting the industry’s growth and development across Taiwan. TBA is best known for organizing the Taipei International Bakery Show (TIBS)—an annual exhibition that highlights the latest baking trends and innovations in Taiwan, attracting professionals and enthusiasts from around the world. Beyond its support for Taiwan’s domestic industry, TBA actively fosters connections with regional and international counterparts. It engages with organizations such as the International Federation of Chinese Bakery & Confectionery Associations (IFCBCA) and the International Union of Bakers and Confectioners (UIBC). These collaborations are what make the association dynamic and resilient in the face of emerging global trends.
TaiHao Medical Inc
Taihao Medical designs and develops AI medical software to help healthcare providers manage the increasing workloads. We focus on breast screening & diagnostic solution by utilizing ultrasound and LDCT AI solutions for lung disease. Our leading products include: 1.BR-FHUSTM Smart System (Free-Hand ABUS): AI for ultrasound breast screening 2.BR-ViewerTM for ABUS 3.BU-CADTM Decision Support: AI for ultrasound breast cancer diagnosis 4.Ti–LUNGTM Decision Support: AI for LDCT lung cancer screening & diagnosis Leading technology & expertise include: 1.Real-Time AI detects suspicious areas in Ultrasound images 2.Advisory Board include scientists & physicians in Taiwan, Japan, China, and USA We have received US FDA, Japan’s PMDA, Taiwan’s TFDA, China’s NMPA, and more than 10 patent licenses. We not only advocate our products to the world, integrate with AI marketplace, but also cooperate with government’s screening program, women breast centers, mammography clinics, insurance companies and ultrasound machine manufacturers. Taihao Medical’s shareholders include CDIB Capital Healthcare Ventures Limited, Japan ＣＥＳデカルト, Top Taiwan Venture Capital Co., Ltd. and CTBC Securities Venture Capital Co., Ltd., who are involved in our capital investing. We strive for integrating our AI products in different types of ultrasound devices. Furthermore, global market expansion has been one of our key landmarks for the past and upcoming years, supported by our strong technical team in related areas. They are highly professional and well experienced. “Early Detection, Early Treatment, Most Lives Saved” is Taihao’s Value Proposition. We aim to be one of the most successful AI Medical companies worldwide. Welcome to follow our Linkedin and notice our continuous milestone, the latest news, and employees’ life in Taihao Medical.
TAHO Pharmaceuticals
AHO is a commercial-stage specialty pharma pioneering in oral, transdermal drug delivery systems. Collaborating with our partners across three continents, our pipeline of medicines targets CNS, Geriatric, and Pediatric therapies that provide caregivers with significant treatment options. From concept to commercial, we have several products launched in major markets. Trusted by partner pharma, we devote toward partner value and innovation. | TAHO Pharmaceuticals, founded in 2010 in Taipei, Taiwan, and listed on the Taipei Exchange, is dedicated to transforming drug delivery with heart and innovation. We specialize in advanced formulations that make oral and injectable medications safer, more effective, and easier to use. Our mission is to enhance patient lives with thoughtful, next-generation solutions for diverse needs, especially those struggling with traditional treatments. Our success stems from our proprietary Transepithelial Delivery System (TDS) platform. It features: Transdermal Delivery: Patches provide steady medication through the skin, eliminating injections or frequent dosing—ideal for chronic care. Transmucosal Delivery: Oral thin films ensure rapid onset, enhanced bioavailability, and improved experience via the mucosa. We’re not merely creating new delivery methods—we are redefining the future of healthcare with compassion, ensuring our innovations bring hope and comfort to patients and caregivers. | TAHO Pharmaceuticals Ltd., founded in 2010 and headquartered in Taipei, Taiwan, is a publicly listed company on the Taipei Exchange. The company focuses on advancing drug delivery through innovative formulation technologies that improve the safety, efficacy, and convenience of existing medications. Leveraging its proprietary Transepithelial Delivery System (TDS) platform, TAHO develops transdermal and transmucosal drug delivery solutions designed to enable efficient drug absorption, improve patient compliance, and optimize therapeutic outcomes. By creating patient-friendly alternatives to traditional oral and injectable medications, TAHO is committed to addressing unmet medical needs and improving quality of life for patients worldwide. | TAHO is an R&D-driven specialty pharma pioneering oral and transdermal drug-delivery systems. TAHO’s Transepithelial Delivery System enables the development of oral dissolving films and transdermal patches for anticoagulants and many other treatments